Gene · 9547
Papers2,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and Validation of Hub Genes with Poor Prognosis in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis. | Int J Gen Med | 2022 | 35431572 | PubTator, text mining | PubMed |
| Dysregulation of CXCL14 promotes malignant phenotypes of esophageal squamous carcinoma cells via regulating SRC and EGFR signaling. | Biochem Biophys Res Commun | 2022 | 35421632 | PubTator, text mining | PubMed |
| Omics-based biomarkers for diagnosis and prediction of kidney allograft rejection. | Korean J Intern Med | 2022 | 35417937 | PubTator, text mining | PubMed |
| Bone Morphogenetic Protein-8B Levels at Birth and in the First Year of Life: Relation to Metabolic-Endocrine Variables and Brown Adipose Tissue Activity. | Front Pediatr | 2022 | 35402348 | PubTator, text mining | PubMed |
| The Impact of Metabolic Syndrome and Type 2 Diabetes Mellitus on Prostate Cancer. | Front Cell Dev Biol | 2022 | 35399507 | PubTator, text mining | PubMed |
| Responses of macrozoobenthos communities to changes in submerged macrophyte biomass in 19 temperate lakes in China. | Environ Sci Pollut Res Int | 2022 | 35381924 | PubTator, text mining | PubMed |
| DNA Methylation Modulates Aging Process in Adipocytes. | Aging Dis | 2022 | 35371604 | PubTator, text mining | PubMed |
| CEMIP as a potential biomarker and therapeutic target for breast cancer patients. | Int J Med Sci | 2022 | 35370456 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Immune and Prognostic Implication of TRIM8 in Breast Cancer. | Front Genet | 2022 | 35368651 | PubTator, text mining | PubMed |
| Tissue-Dependent Adaptations and Functions of Innate Lymphoid Cells. | Front Immunol | 2022 | 35359972 | PubTator, text mining | PubMed |
| Upregulation of Yin-Yang-1 Associates with Proliferation and Glutamine Metabolism in Esophageal Carcinoma. | Int J Genomics | 2022 | 35359580 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Based on EPOR Expression With Potential Value in Prognosis and Tumor Immunity in 33 Tumors. | Front Oncol | 2022 | 35359375 | PubTator, text mining | PubMed |
| A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma. | Clin Cancer Res | 2022 | 35349638 | PubTator, text mining | PubMed |
| Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer. | Semin Cancer Biol | 2022 | 35346803 | PubTator, text mining | PubMed |
| An osteoarthritis subtype characterized by synovial lipid metabolism disorder and fibroblast-like synoviocyte dysfunction. | J Orthop Translat | 2022 | 35330945 | PubTator, text mining | PubMed |
| Polymeric Hydrogels for In Vitro 3D Ovarian Cancer Modeling. | Int J Mol Sci | 2022 | 35328686 | PubTator, text mining | PubMed |
| Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma. | Curr Oncol | 2022 | 35323326 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma. | World J Surg Oncol | 2022 | 35287670 | PubTator, text mining | PubMed |
| Transcriptional Expressions of ALDH1A1/B1 as Independent Indicators for the Survival of Thyroid Cancer Patients. | Front Oncol | 2022 | 35280765 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9547/papers?page=44